Robert Stone

Robert Stone

Alston & Bird

Contact

Readers' Choice Awards

Healthcare
Healthcare
View Bio
RSS

Latest Posts › Coronavirus/COVID-19

Share:

Health Care Week in Review | Senate Passes First Budget Resolution; DOJ Opts to Continue Defense in Braidwood SCOTUS Case

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

2/24/2025  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Health Insurance , Healthcare , Healthcare Facilities , Medicaid , Medicare , Public Health , Regulatory Requirements , Vaccinations

Health Care Week in Review: Members of Congress Introduce Bipartisan, Bicameral PBM Reform Bill; ASTP/ONC Releases TEFCA Final...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

12/18/2024  /  AHRQ , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Health Care Providers , Health Insurance , Healthcare , Pharmacy Benefit Manager (PBM) , Public Health , SAMHSA

Health Care Week in Review: Biden Administration Submits Disaster Aid Request; Senators Propose New Health Care Cybersecurity...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

11/25/2024  /  Biden Administration , Centers for Disease Control and Prevention (CDC) , Coronavirus/COVID-19 , Cybersecurity , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare , HRSA , Medicaid , Medicare , National Institute of Health (NIH) , Prescription Drugs , SAMHSA

Health Care Week in Review: House Committee on Oversight and Accountability Held a Hearing on PBMs; HHS Reorganizes Technology,...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

7/29/2024  /  Biosimilars , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Electronic Protected Health Information (ePHI) , Federal Food Drug and Cosmetic Act (FFDCA) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare , Healthcare Facilities , Medical Devices , National Institute of Health (NIH) , Pharmaceutical Industry , Pharmacy Benefit Manager (PBM) , Prescription Drugs , Public Health

Health Care Week in Review: House Held a Markup of 23 Bills; Senators Announced a Proposal on Primary Care Payment Reform

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

5/20/2024  /  Centers for Disease Control and Prevention (CDC) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Federal Food Drug and Cosmetic Act (FFDCA) , Food and Drug Administration (FDA) , Health Care Providers , Life Sciences , Medical Devices , National Institute of Health (NIH) , Pharmaceutical Industry , Prescription Drugs , Public Health

Health Care Week in Review: CMS Finalizes Medicaid DSH Rule and House Launches Bipartisan AI Task Force

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

2/26/2024  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Clinical Trials , Coronavirus/COVID-19 , Digital Health , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Facilities , Hospitals , Medicaid , Medical Devices , Pharmaceutical Industry , Popular , Public Health Emergency

Health Care Week In Review: HHS Selects the First 10 Drugs for Medicare Drug Price Negotiation

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

9/6/2023  /  AHRQ , Biologics , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Long Term Care Facilities , Medicare , National Institute of Health (NIH) , Pharmaceutical Industry , Popular , Prescription Drugs , Skilled Nursing Facility

Health Care Week In Review: CMS Releases SNF and IPPS Final Rules

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

8/7/2023  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Facilities , Medicare , Skilled Nursing Facility

Health Care Week in Review: Emerging Technology Coverage Pathway, Long COVID Advisory

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

6/26/2023  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medical Devices , National Institute of Health (NIH) , Pharmaceutical Industry , Popular , SAMHSA

Health Care Week in Review: HHS Coverage Flexibilities and MedPAC/MACPAC Reports

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

6/19/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , DEA , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Popular , Prescription Drugs , Telehealth , Telemedicine

Health Care Week In Review: Fifth Circuit Review of ACA Requirement and HRSA Funds Health Centers

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

5/22/2023  /  Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Mental Health , Nursing Homes , Popular , Public Health Emergency

Health Care Week In Review: COVID-19 PHE Expires, DEA Issues Final Rule

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

5/15/2023  /  Biologics , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Controlled Substances , Coronavirus/COVID-19 , DEA , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Popular , Prescription Drugs , Public Health Emergency , Telehealth , Telemedicine

Health Care Week in Review: Senate Votes to End COVID-19 National Emergency, CMS Releases Rate Notice

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

4/3/2023  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medical Devices , Medicare , Popular , Public Health Emergency

Health Care Week in Review: President’s Budget and ASPR Cybersecurity Guide

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

3/13/2023  /  Centers for Disease Control and Prevention (CDC) , Coronavirus/COVID-19 , Cybersecurity , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , National Institute of Health (NIH) , Popular , Public Health , Public Health Emergency

Health Care Week in Review: FY 2024 Appropriations Process Begins

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

2/27/2023  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Hospitals , Medicaid , Medicare , National Institute of Health (NIH) , SAMHSA

Health Care Week in Review: CMMI Announces Three New Models, President Biden Issues Executive Order

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

2/20/2023  /  Abbreviated New Drug Application (ANDA) , Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medicare , National Institute of Health (NIH) , Pharmaceutical Industry

Health Care Week in Review: State of the Union and HHS Guidance on Drug Rebates and PHE

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

2/13/2023  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medical Devices , Medicare , National Institute of Health (NIH) , Pharmaceutical Industry , Prescription Drugs , Public Health Emergency , Vaccinations

Health Care Week in Review: Biden Administration Plans to End COVID-19 PHE on May 11

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

2/7/2023  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medical Devices , Medicare , Public Health Emergency

Pre-pandemic Misconduct Allows DOJ to Claw Back Paycheck Protection Program Funds

Our Health Care and Health Care Litigation Groups analyze how the Department of Justice used the False Claims Act and Stark Law to require a health care provider to repay federal COVID-19 funding....more

5/13/2022  /  Coronavirus/COVID-19 , Department of Justice (DOJ) , False Claims Act (FCA) , Health Care Providers , Medical Testing , Paycheck Protection Program (PPP) , Stark Law

HHS Announces $20 Billion Phase 3 General Distribution

Our Health Care Group reviews the nuances for eligibility and applying for the latest round of COVID-19 relief from the CARES Act’s Provider Relief Fund....more

10/5/2020  /  CARES Act , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Health Care Providers , HRSA , Provider Relief Fund , Reporting Requirements

CMS Issues Blanket Waivers from Physician Self-Referral Law Sanctions

Our Health Care Group dives into the Centers for Medicare & Medicaid Services’ Stark Law waivers for physicians and hospitals fighting the coronavirus (COVID-19) pandemic. - COVID-19 Purpose and 18 blanket waivers...more

4/2/2020  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Stark Law , Waivers

CMS Announces Expansion of Medicare’s Accelerated and Advance Payment Program

Our Health Care Group highlights how the Centers for Medicare & Medicaid Services (CMS) has expanded the Accelerated and Advance Payment Program to respond to the coronavirus (COVID-19) pandemic....more

3/31/2020  /  Accelerated Payments , CARES Act , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Health Care Providers , Hospitals , Medicare , Physician Medicare Reimbursements , Physicians , Relief Measures
22 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide